International Conference on Hypertension and Vascular Health

ICHVH

31st Aug – 1st Sep 2026 Prague, Czech Republic

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

10% OFF on Registration.
Use Coupon Code → EARLY10

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Registration Summary

Conference ICHVH

Date 31st Aug – 1st Sep 2026

Location Prague, Czech Republic

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Innovations in Hypertension Management +

This track will explore the latest advancements in the diagnosis and treatment of hypertension. Emphasis will be placed on novel therapeutic approaches and technologies that enhance blood pressure control.

SDG 3 SDG 4

02 Vascular Health and Disease Mechanisms +

This session will delve into the pathophysiological mechanisms underlying vascular health and disease. Researchers are invited to present findings that elucidate the relationship between vascular function and cardiovascular risk.

SDG 3 SDG 9

03 Cardiovascular Risk Assessment Strategies +

This track will focus on the development and validation of tools for assessing cardiovascular risk in diverse populations. Discussions will include the integration of clinical and demographic factors in risk prediction models.

SDG 3 SDG 10

04 Heart Disease Prevention: Evidence and Guidelines +

This session aims to review current guidelines and evidence-based practices in heart disease prevention. Participants will discuss the effectiveness of lifestyle interventions and pharmacological strategies.

SDG 3 SDG 4

05 Clinical Cardiology: Challenges and Innovations +

This track will address contemporary challenges in clinical cardiology, including patient management and treatment adherence. Innovative approaches to improve patient outcomes will be highlighted.

SDG 3 SDG 10

06 Hypertension Guidelines: Implementation and Impact +

This session will evaluate the implementation of hypertension management guidelines across various healthcare settings. The focus will be on assessing the impact of these guidelines on patient outcomes.

SDG 3 SDG 4

07 Cardiology Research: Translational Perspectives +

This track will showcase cutting-edge research in cardiology with a focus on translational applications. Presentations will highlight how laboratory findings can inform clinical practice.

SDG 3 SDG 9

08 Public Health Approaches to Hypertension Control +

This session will explore public health initiatives aimed at reducing the prevalence of hypertension. Strategies for community engagement and policy development will be discussed.

SDG 3 SDG 11

09 Emerging Therapies in Cardiovascular Disease +

This track will focus on the latest emerging therapies for the treatment of cardiovascular disease. Participants will discuss the efficacy and safety of novel pharmacological agents and interventions.

SDG 3 SDG 4

10 Patient-Centered Care in Hypertension Management +

This session will emphasize the importance of patient-centered approaches in managing hypertension. Discussions will include strategies for enhancing patient engagement and adherence to treatment.

SDG 3 SDG 10

11 Global Perspectives on Hypertension and Vascular Health +

This track will provide a platform for discussing global trends and disparities in hypertension and vascular health. Researchers will share insights on how cultural and socioeconomic factors influence cardiovascular health outcomes.

SDG 3 SDG 10